Article Details

Asterias Biotherapeutics Reports Third Quarter Results

Retrieved on: 2018-11-09 05:11:15

Tags for this article:

Click the tags to see associated articles and topics

Asterias Biotherapeutics Reports Third Quarter Results. View article details on hiswai:

Excerpt

<div>... from the Novo transaction, on October 1, 2018 the Company had cash and cash equivalents of $8.5 million and $6.2 in marketable <b>equity securities</b>.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo